Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-079467
Filing Date
2013-10-31
Accepted
2013-10-31 08:31:22
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19836_110q.htm 10-Q 1188439
2 EX-31.1 a13-19836_1ex31d1.htm EX-31.1 12449
3 EX-31.2 a13-19836_1ex31d2.htm EX-31.2 12318
4 EX-32.1 a13-19836_1ex32d1.htm EX-32.1 8662
  Complete submission text file 0001104659-13-079467.txt   9766909

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alks-20130930.xml EX-101.INS 1255502
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alks-20130930.xsd EX-101.SCH 87818
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alks-20130930_cal.xml EX-101.CAL 78808
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alks-20130930_def.xml EX-101.DEF 526268
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT alks-20130930_lab.xml EX-101.LAB 1713533
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alks-20130930_pre.xml EX-101.PRE 813610
Mailing Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000
Business Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000 00-353-1-649-2000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 131180929
SIC: 2834 Pharmaceutical Preparations